NANOBIOTECH ·First 'nano' technologies yield fruit in the lab and clinic with the promise of more to come.From R&D analysis and pathogen detection to clinical diagnosis and drug delivery, the biomedical applications of nanotechnology, while still in their infancy, are starting to yield real results. While much of the work is the province of academia, increasingly clinical labs as well as biotech and pharmaceutical companies are getting involved. Among several recent notable announcements:
· Johnson & Johnson and Roche licensed Elan's NanoCrystal technology, which enhances the performance of drugs with poor water-solubility.
· Researchers at Massachusetts General Hospital announced in PLoS Medicine that an injectable solution of magnetic nanoparticles can be used to track cancer in patients, reducing the need for surgery.
No comments:
Post a Comment